Skip to content

Spermatozoa Morphology Selection by Thermotaxis

Sperm Selection by Thermotaxis: a Novel Technique to Enhance Assisted Reproductive Technologies' Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04849156
Enrollment
20
Registered
2021-04-19
Start date
2021-04-12
Completion date
2022-03-09
Last updated
2022-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male Infertility

Keywords

Spermatozoa selection, Thermotaxis, Testicular and sperm biology

Brief summary

This study aims to eventually assess the usefulness of thermotaxis for sperm selection in routine clinical practice.

Detailed description

As the world's total fertility rate decline, every year more couples require assisted reproductive technologies (ART) in order to achieve their desire to become parents. However, these techniques are not guaranteed solutions and still many couples with unexplained infertility fail to conceive. One of the reasons might be the relative selection of spermatozoa for the following ART. To minimize a poor selection made by the operator and to standardize spermatozoa selection, we suggest a new method might be used in combination with the routine spermatozoa selection techniques. Thermotaxis might be used in the ART setting as a tool to select the best spermatozoa as human spermatozoa after capacitation responds positively to a temperature gradient change. Moreover, this might be the possible navigation mechanism of spermatozoa in the female genital tract. We hypothesize that spermatozoa selected by thermotaxis behavior might increase the morphologically normal spermatozoa number in the cohort used during ART. The aim of this study is to evaluate if thermotaxis is a good method for selecting morphologically normal sperm for ART.

Interventions

OTHERSperm selection by thermotaxis

Selection of healthy sperm by thermotaxis procedure

Sponsors

Instituto Valenciano de Infertilidade de Lisboa
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 39 Years

Inclusion criteria

* Age: ≥18 and \<40 years old. * Spermatozoa concentration \>15 x 10⁶ /mL in all sperm analysis performed in the last 24 months. * Spermatozoa mobility \>32% in all sperm analysis performed in the last 24 months. * Spermatozoa morphology \>4% in all sperm analysis performed in the last 24 months. * Signed and dated informed consent

Exclusion criteria

* Use of antibiotics, intravenous illicit drugs, chemotherapy or radiotherapy usage in the last 3 months. * Active smoking (during the preceding 12 months). * More than 3 days prior to the last ejaculation.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of normal spermatozoa morphology11 monthsAnalysis of sperm samples following thermotaxis (intervention) versus the controls (without thermotaxis).

Countries

Portugal

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026